Corcept Therapeutics Incorporated (CORT)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 482,375 450,026 428,153 413,824 401,858 397,624 392,027 380,229 365,978 352,891 343,087 340,064 353,874 356,034 351,212 334,904 306,486 285,422 268,362 258,417
Receivables US$ in thousands 42,823 35,926 33,153 33,657 32,857 30,314 29,864 28,178 29,025 27,908 29,020 23,900 27,498 23,557 23,925 28,084 19,928 22,405 19,774 19,218
Receivables turnover 11.26 12.53 12.91 12.30 12.23 13.12 13.13 13.49 12.61 12.64 11.82 14.23 12.87 15.11 14.68 11.93 15.38 12.74 13.57 13.45

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $482,375K ÷ $42,823K
= 11.26

Over the past eight quarters, Corcept Therapeutics Inc has maintained a relatively stable receivables turnover ratio, ranging from a low of 11.73 in Q4 2023 to a high of 13.99 in Q1 2022. The receivables turnover ratio measures how efficiently the company is able to collect payments from its customers. A higher turnover ratio indicates that the company is collecting its accounts receivables more quickly.

In this case, the company's receivables turnover has generally been above 11, with an average around 13. This suggests that Corcept Therapeutics Inc has been effective in managing and collecting its accounts receivables. A consistent and high receivables turnover ratio is positive as it signifies a healthy cash flow cycle and efficient credit management practices.

However, a slight decrease in the receivables turnover ratio in recent quarters could indicate potential issues with collecting payments from customers promptly. It may be worth further investigation to understand the reasons behind this trend and to ensure that the company's accounts receivables are being managed effectively to maintain a healthy cash flow.


Peer comparison

Dec 31, 2023